Friday, May 9, 2025

LATEST ARTICLES

Venture Capital

Gandeeva Raises $40M in Series A Funding to Develop Novel Therapies Based on Precision Imaging of Protein-Drug Interactions

Life Sciences Times - 0
Biotech

Juvenescence Ltd. Portfolio Company Hails Successful Limb Regeneration in Adult Frogs

Life Sciences Times - 0
People on the Move

Three in Four CEOs Fear Losing Their Jobs, Says AlixPartners Survey

Life Sciences Times - 0
Venture Capital

Comera Life Sciences to Become Publicly Traded via Business Combination with OTR Acquisition Corp.

Life Sciences Times - 0
Medtech

Komodo Health to Provide Powerful Insights Platform to Rare Disease Patient Advocacy Organizations

Life Sciences Times - 0
Pharma

U.S. FDA Approves New Label Update for CAR T-Cell Therapy Yescarta® Showing Prophylactic Steriod Use Improves Management of Cytokine Release Syndrome

Life Sciences Times - 0
Venture Capital

468 Capital Raises $400 Million Fund II

Life Sciences Times - 0
Pharma

Merck and Ridgeback’s Molnupiravir, an Investigational Oral Antiviral COVID-19 Medicine, Demonstrated Activity Against Omicron Variant in In Vitro Studies

Life Sciences Times - 0
Venture Capital

causaLens Raises $45m Series A to Scale Human-centered AI That Understands Cause-and-effect

Life Sciences Times - 0
Medtech

Insulet Announces FDA Clearance of its Omnipod® 5 Automated Insulin Delivery System, First Tubeless System with Smartphone Control

Life Sciences Times - 0
1...457458459...627Page 458 of 627

Most Popular

Load more

Recent Comments

EDITOR PICKS

THIS WEEK'S STORIES

POPULAR CATEGORY

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Contact us: [email protected]

FOLLOW US

© Newspaper WordPress Theme by TagDiv